Ideal cardiovascular health and inflammation in European adolescents: The HELENA study by González-Gil, E.M. et al.
Accepted Manuscript
Ideal cardiovascular health and inflammation in European adolescents: the HELENA
study
E.M. González-Gil, J. Santabárbara, J. Ruiz, S. Bel-Serrat, I. Huybrechts, R. Pedrero-
Chamizo, A. de la O, F. Gottrand, A. Kafatos, K. Widhalm, Y. Manios, D. Molnar, S.
De Henauw, M. Plada, M. Ferrari, G. Palacios Le Blé, A. Siani, M. González-Gross,




To appear in: Nutrition, Metabolism and Cardiovascular Diseases
Received Date: 16 July 2016
Revised Date: 13 December 2016
Accepted Date: 14 December 2016
Please cite this article as: González-Gil E, Santabárbara J, Ruiz J, Bel-Serrat S, Huybrechts I, Pedrero-
Chamizo R, de la O A, Gottrand F, Kafatos A, Widhalm K, Manios Y, Molnar D, De Henauw S, Plada
M, Ferrari M, Palacios Le Blé G, Siani A, González-Gross M, Gómez-Martínez S, Marcos A, Moreno
Aznar L, on behalf of the HELENA study, Ideal cardiovascular health and inflammation in European
adolescents: the HELENA study, Nutrition, Metabolism and Cardiovascular Diseases (2017), doi:
10.1016/j.numecd.2016.12.003.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all














Ideal cardiovascular health and inflammation in European adolescents: the 1 
HELENA study. 2 
 3 
González-Gil, EM1,2,3,4, Santabárbara, J5, Ruiz, J6, Bel-Serrat, S1, Huybrechts, I7,8, 4 
Pedrero-Chamizo, R4,9, de la O, A10, Gottrand, F11, Kafatos, A12, Widhalm, K13, Manios, 5 
Y14, Molnar, D15, De Henauw, S8, Plada, M12, Ferrari, M16, Palacios Le Blé, G4,9, Siani, 6 
A17, González-Gross, M4,9, Gómez-Martínez, S18, Marcos, A18 and Moreno Aznar, 7 
LA1,2,3,4 on behalf of the HELENA study. 8 
 9 
1GENUD "Growth, Exercise, NUtrition and Development" Research Group, Faculty of 10 
Health Sciences. Universidad de Zaragoza, Spain 11 
2Instituto Agroalimentario de Aragón (IA2)  12 
3Instituto de Investigación Sanitaria Aragón (IIS Aragón)  13 
4Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y 14 
Nutrición (CIBERObn)  15 
5Department of Preventive Medicine and Public Health, University of Zaragoza. 16 
Zaragoza, Spain. 17 
6PROmoting FITness and Health through physical activity research group (PROFIT), 18 
Department of Physical Education and Sports, Faculty of Sport Sciences, University of 19 
Granada, Granada, Spain 20 
7International Agency for Research on Cancer (IARC), Lyon, France. 21 
8Department of Public Health, Ghent University, Ghent, Belgium 22 
9ImFine Research Group. Facultad de Ciencias de la Actividad Física y del Deporte-23 
INEF, Universidad Politécnica de Madrid, Madrid  24 
10Department of Medical Physiology, School of Medicine, University of Granada, 25 
Granada, Spain. 26 
11Univ Lille 2, INSERM U995, CHU-Lille, France. 27 
12Preventive Medicine and Nutrition Unit, School of Medicine, University of Crete, 28 
Crete, Greece. 29 
13Department of Pediatrics, Division of Clinical Nutrition, Medical University of 30 
Vienna, Vienna, Austria. 31 
14Department of Nutrition and Dietetics, Harokopio University, Athens, Greece. 32 















 Research Center for Food and Nutrition, Council for Agricultural Research and 34 
Economics, Rome, Italy 35 
17Unit of Epidemiology and Population Genetics, Institute of Food Sciences, National 36 
Research Council, Avellino, Italy 37 
18Immunonutrition Group, Institute of Food Science, Technology and Nutrition. 38 
(ICTAN). Spanish National Research Council (CSIC). Madrid, Spain 39 
 40 
Corresponding author: 41 
Esther María González Gil, GENUD (Growth, Exercise, NUtrition and Development) 42 
Research Group. Faculty of Health Sciences. Universidad de Zaragoza. C/ Pedro 43 
Cerbuna, 12. 50009 Zaragoza.  44 
Fax: +34 976 76 17 52 / Telephone number: +34 876 55 37 56 45 
 46 
Word count for abstract: 245 47 
Word count for text: 2990 48 
Number of references: 30 49 
Number of tables: 4 (plus two presented as supplementary material) 50 
















Background and aims: Inflammation plays a key role in atherosclerosis and this 54 
process seems to appear in childhood.  The ideal cardiovascular health index (ICHI) has 55 
been inversely related to atherosclerotic plaque in adults. However, evidence regarding 56 
inflammation and ICHI in adolescents is scarce. The aim is to assess the association 57 
between the ICHI and inflammation in European adolescents.  58 
Methods and results: 543 adolescents (251 boys and 292 girls) from the Healthy 59 
Lifestyle in Europe by Nutrition in Adolescence (HELENA) study, a cross-sectional 60 
multi-center study including 9 European countries, were measured. C-reactive protein 61 
(CRP), complement factors C3 and C4, leptin and white blood cell counts were used to 62 
compute an inflammatory score. Multilevel linear models and multilevel logistic 63 
regression were used to assess the association between ICHI and inflammation 64 
controlling by covariates. Higher ICHI was associated with a lower inflammatory score, 65 
as well as with several individual components, both in boys and girls (p<0.01). In 66 
addition, adolescents with at least 4 ideal components of the ICHI had significantly 67 
lower inflammatory score and lower levels of the study biomarkers, except CRP. 68 
Finally, the multilevel logistic regression showed that for every unit increase in the 69 
ICHI, the probability of having an inflammatory profile decreased by 28.1% in girls. 70 
Conclusion: Results from this study suggest that a better ICHI is associated with a 71 
lower inflammatory profile already in adolescence. Improving these health behaviors, 72 
and health factors included in the ICHI, could play an important role in CVD 73 
prevention. 74 
 75 

















Cardiovascular diseases (CVD), such as coronary artery disease, are the result of 80 
atherosclerosis progression (1). Evidence suggest that inflammation has a key role in the 81 
origin and development of atherosclerosis (2) as it triggers the formation of the fatty 82 
streak and its development into complex plaque (3). Atherosclerosis has its origins in 83 
childhood and is associated with early risk factors (4), yet symptoms may appear later in 84 
life (5). The relationship between inflammation and cardiovascular diseases is present 85 
already in childhood (6). 86 
High concentrations of C-reactive protein (CRP) seem to track from childhood to 87 
adulthood (7). However, there are other biomarkers contributing to the characterization 88 
of the inflammatory process such as cytokines,(8) e.g. tumor necrosis factor alpha 89 
(TNF-alpha), or interleukins, e.g. interleukin 6 (IL-6). Nevertheless, other biomarkers 90 
have also been considered (9). 91 
In addition, CRP is not always associated with atherosclerosis diagnosed by image 92 
techniques,(10) therefore, the use of a score that combines several inflammatory 93 
biomarkers could provide an overall estimation of the inflammatory status. A previous 94 
study (11) developed an inflammatory score, which included CRP, complement factors 95 
C3 and C4, leptin and white blood cells (WBC) being selected due to their high 96 
correlation with fatness and traditional cardio-metabolic risk factors.  97 
 98 
In 2010, the American Heart Association (AHA) released the ideal cardiovascular 99 
health index (ICHI), (12) including four health behaviors and three health factors. The 100 
behavior-related criteria were: non-smoking, being physically active, having normal 101 
body mass index (BMI), and eating a healthy diet, while the health factors included 102 
were: normal blood pressure, plasma total cholesterol and glucose. The ICHI has been 103 
inversely related to the presence of atherosclerotic plaque in adults (13); therefore, it 104 
could represent a useful epidemiological tool to assess the cardiovascular profile. 105 
Although there are some studies assessing the relationship between cardiovascular 106 
profile and metabolic risk factors in adolescents or young adults,(14, 15) there is not 107 
sufficient evidence on the association between inflammation and cardiovascular health 108 














The aims of the present study were to to assess the association between ICHI and 110 
inflammatory markers in European adolescents and to examine the use of an 111 
















Study design 115 
The HELENA study is a cross-sectional multi-center study (n=3528) conducted in 10 116 
European cities: Athens and Heraklion in Greece, Dortmund in Germany, Ghent in 117 
Belgium, Lille in France, Pecs in Hungary, Rome in Italy, Stockholm in Sweden, 118 
Vienna in Austria and Zaragoza in Spain. HELENA study has been previously 119 
described(16). 120 
The study was performed according to the ethical guidelines of the Edinburgh revision 121 
of the 1964 Declaration of Helsinki (2000). The local Ethics Committees of each center 122 
approved the protocol and written informed consent was obtained.  123 
 124 
Study population 125 
Out of the total HELENA sample, one third from the 10 cities was chosen to provide 126 
blood samples (n=1089, 31%). Therefore, around 100 adolescents in each city were 127 
selected by means of the immunological parameters which were those with the highest 128 
variability within the blood measurements that were included in the study (16). Overall, 129 
543 participants (251 boys and 292 girls) met the inclusion criteria for the present 130 
analysis: having data on the variables included in the ICH index and having measured 131 
the CRP, C3 and C4 complement factors, leptin and WBC. (Supplementary Figure 1) 132 
 133 
Physical examinations 134 
Weight and height were measured in underwear and barefoot with a SECA 861 (Seca 135 
Ltd) and with a stadiometer SECA 225 (Seca Ltd). In addition, body mass index (BMI) 136 
was calculated as body weight in kilograms divided by the square of height in meters. 137 
Pubertal maduration was examined by a clinician and was assessed according Tanner 138 
(5-point-scale). Systolic and diastolic blood pressure was measured with an automatic 139 
oscillometric device (Omron M6). Participants were seated in a quiet room for ten 140 
minutes with their backs supported and feet on the ground. The lowest value of the two 141 
measurements, taken with a difference of 5 minutes, was recorded and the mean was 142 
used in data analysis. All anthropometric measures were taken following a standardized 143 
protocol. 144 
 145 














A modified version of the family affluence scale (FAS) was used as a proxy of 147 
socioeconomic status (SES). The adolescents completed a questionnaire asking about 148 
the numbers of cars and computers at home, having internet and whether the adolescent 149 
had his or her own room. In the HELENA study, the FAS was modified by replacing 150 
‘frequency of family holidays’ by ‘Internet availability at home’. Adolescents were 151 
scored from 0 (very low SES) to 8 (very high SES).  152 
 153 
Blood analysis 154 
Blood withdrawal was performed in fasting status. WBC counts and percentages were 155 
determined with automated blood cell counters. C-reactive protein (CRP) levels were 156 
quantified by immunoturbidimetry (AU 2700, Olimpus, Rungis, France). Serum C3 and 157 
C4 complement factors were analyzed by nephelometry (Behring Diagnostics, CA, 158 
USA). The coefficient of variation (inter-assay precision) was 1.9% for CRP, 1.4% for 159 
C3, and 1.2% for C4. Detection limits (sensitivity) were 0.007 mg/L for CRP, 0.01 g/L 160 
for C3, and 0.002 g/L for C4. Serum leptin (ng/mL) was measured using the RayBio 161 
Human Leptin ELISA (Enzyme-Linked Immunosorbent Assay; RayBiotech, Norcross, 162 
GA, USA) kit. The sensitivity of the leptin assay was <6 pg/mL, with intra-assay and 163 
interassay coefficients of variation of <10% and <12%. 164 
  165 
Ideal cardiovascular health index 166 
The AHA released the ICHI in 2010 (12) with the cut off values for adolescents.  167 
 168 
Health behaviors  169 
Four health behaviors were considered for the ICH index: smoking behavior, physical 170 
activity, BMI and diet.  171 
Smoking status was categorized considering those who had never smoked as having an 172 
ideal smoking behavior. Adolescents who performed more than 60 min of moderate to 173 
vigorous self-reported exercise every day were classified as having an ideal physical 174 
activity level. BMI z-score and BMI categories were derived using the British 1990 175 
Growth Reference Data from the Child Growth.(17, 18) 176 
To assess dietary intake the HELENA-Dietary Assessment Tool (HELENA-DIAT)(19), 177 
a self-report dietary recall based on six meal occasions, was used. The dietary indicators 178 
used to assess ideality of the diet were: consumption of fruit and vegetables (more than 179 














10 g of carbohydrates per day), sodium (less than 1500 mg per day), and soft drinks 181 
(less than 145 mL per day). Having at least 4 of these indicators classified as ‘ideal’ was 182 
considered as ideal healthy diet. 183 
 184 
 185 
Health factors 186 
The cut-off for the biomarkers assessed to consider them ideal was <170mg/dL for 187 
plasma total cholesterol and <100mg/dL for glucose. 188 
The lower value of the diastolic blood pressure and systolic blood pressure was used in 189 
the analysis to classify blood pressure status as ideal when lower than the 90th c ntile 190 
for the blood pressure (12). 191 
 192 
Inflammatory score 193 
A continuous score was computed from some inflammatory biomarkers: CRP, C3, C4, 194 
WBC and leptin. The selection of these biomarkers was based on a preliminary analysis 195 
with fatness and traditional cardio-metabolic risk factors as previously assessed within 196 
the HELENA study (11) (Supplementary material table 1).  197 
Standardized values of the biomarkers were calculated for boys and girls and by 1-year 198 
age groups with the following formula: standardize value= (value – mean) / standard 199 
deviation (SD), as has been done elsewhere.(11) Z-scores from biomarkers were 200 
summed up to create a score of inflammation.  201 
 202 
Statistical analysis 203 
Analyses were stratified by sex. Normality assumption was checked and transformation 204 
was performed if required. Partial correlations, adjusted for age, sex, pubertal stage and 205 
center, between traditional and nontraditional cardio metabolic biomarkers were 206 
performed for the selection of the inflammatory biomarkers for the inflammatory score. 207 
 208 
Student t test and chi-squared test were performed for the differences between the study 209 
participants by sex. Additionally, ANCOVA was performed to assess mean value of the 210 
inflammatory score by the ideal category and non-ideal category of each component of 211 















Multilevel linear models (level: center) were used to assess the associations between the 214 
inflammatory score (dependent variable) and the ICHI. Two different models were 215 
carried out. In the first model, the covariates used were Tanner and SES while in the 216 
second model the cardiorespiratory fitness was included. Frequencies between number 217 
of components of the ICHI and inflammatory score were assessed and the p for trend 218 
was calculated. 219 
Finally, a multilevel logistic regression (level: center) was performed. The 220 
inflammatory index was transformed into a categorical variable using the median value 221 
in order to split the sample into two groups (I: > -0.737; II: ≤ -0.737 for boys and I: > -222 
0.268; II: ≤-0.268 for girls) and the ideal cardiovascular health index was considered as 223 
independent variable. Two different models were performed. In the first model, the 224 
covariates used were Tanner and SES while in the second model the cardiorespiratory 225 
fitness was included. Interactions between covariates and dependent variable were 226 
assessed before calculating the multivariate regression model using Wald test in both 227 
multilevel models: linear and logistic, and no statistical significance was observed in 228 
any. Also, multicollinearity was assessed by means of variance inflation factor values 229 
calculation for covariates in each multilevel linear model, and all were < 10. 230 
Data were managed and analyzed with SPSS Statistics v.19 and R software with lme4 231 
















Baseline characteristics are shown in Table 1. There were significant differences by sex 235 
in some of the ICHI components and some biomarkers. None of the boys and only 9% 236 
of the girls followed a healthy diet, almost 47% of the girls had high total cholesterol 237 
levels and 40% of the girls did not comply with PA guidelines. Results for the selection 238 
of the inflammatory biomarkers are found in Supplementary table 1. Differences in 239 
mean concentration of the inflammatory score by the categories of each ICHI 240 
component are presented in Supplementary table 2. Significant sex differences were 241 
found in BMI, physical activity and blood pressure. Plasma glucose showed significant 242 
differences by category of ICHI component in boys. 243 
 244 
Results for the multilevel linear models of the ICHI are presented in Table 2, for boys, 245 
and Table 3, for girls. In model 1, the ICHI was significantly and inversely related to the 246 
inflammatory score and its components: inflammatory score (p<0.001 for boys and 247 
girls), C3 (p=0.001 for boys and p<0.001 for girls), C4 (p=0.002 for boys and p=0.001 248 
for girls), WBC (p=0.017 for girls) and log-leptin (p<0.001 for boys and girls). In model 249 
2, the biomarkers significantly and inversely associated with the ICH index were: 250 
inflammatory score (p=0.005 for boys and p=0.005 for girls), C3 (p=0.001 in girls), C4 251 
(p=0.004 in boys and p=0.039 in girls) and log-leptin (p<0.001 in boys and p=0.006 in 252 
girls). Also, lower levels of inflammation were associated with a higher number of 253 
components of the ICH index in boys (p<0.001) and girls (p<0.001) (Figure 1).  254 
 255 
Finally, the multilevel logistic regression (Table 4) showed the probability of having a 256 
higher or lower inflammatory state when increasing one unit of the ICHI. For boys, 257 
when increasing the ICHI with one unit, the probability of having a higher 258 
inflammatory status decreased 30.7% (OR=0.693, 95%CI: 0.544-0.883, p=0.003) in the 259 
model 1, while this probability decreased 26.5% (OR=0.735, 95%CI: 0.533-1.014 260 
p=0.061) in model 2. In girls, when increasing the ICHI with one unit the probability of 261 
having a higher inflammatory status decreased 22.3% (OR=0.677, 95%CI: 0.539-0.850, 262 
p<0.001) in the first model and 28.1% (OR=0.719, 95%CI: 0.534-0.969, p=0.031) for 263 















DISCUSSION  266 
 267 
Findings from this study suggest that the ICHI proposed by the AHA is negatively 268 
associated with inflammation, measured by biomarkers and an inflammatory score, in a 269 
sample of European adolescents.  270 
Less than optimal cardiovascular health during adolescence seems to be critical in the 271 
development of future CVD.(20) A very low prevalence of the ICHI has been shown in 272 
a U.S sample of adolescents, especially regarding both behavioral components, physical 273 
activity and diet.(21) Furthermore, in another study in adolescents, the ICHI was 274 
inversely associated with aortic intima-media and directly associated with aortic 275 
elasticity, already in adolescence, supporting the relevance of this tool as part of a 276 
primary prevention of future cardiovascular events.(22)   277 
However, none of the European adolescents included in our study sample met the 7 278 
components of the ICHI. This result is in line with previous studies reporting the same 279 
outcome in adolescents (14, 20, 22). Maybe these results are due to the low scores of the 280 
ideal diet score component; this component includes at least four ideal diet criteria out 281 
of five, and was also the component least often met in our sample, 1.7%. In studies 282 
performed in adults, the ideal diet score was also the less frequent component; 283 
prevalence being <1%(23) and 0.4%(24). In our sample, among the diet components, 284 
the optimum level of sodium intake was achieved only by 8.7% of the adolescents, 285 
being the most difficult criteria to meet, but also one of the most challenging criteria to 286 
measure accurately. In contrast, having <100mg/dL for glucose was the most commonly 287 
achieved component of the ICHI since 91.2% of our sample met this criteria. 288 
 289 
In our sample, we observed a negative association between ICHI and the inflammatory 290 
score, suggesting that the higher the ICHI the lower the inflammatory score. To our 291 
knowledge, there are no previous studies assessing the relation between ICHI and 292 
inflammation in adolescence. However, a previous study observed that ICHI in 293 
adolescence was a good predictor of cardio-metabolic health in adulthood (20). As, 294 
individually, the components of the ICHI, such as cardiovascular risk factors, have been 295 
already related to biomarkers of inflammation(25). It seems that cardiovascular risk 296 














In the current study, the observed associations were found using the ICHI as a 7-298 
component variable and the inflammatory score, independently of sex. However, the 299 
ICHI was associated with all the individual biomarkers of the inflammatory score 300 
except CRP. This protein is the most widely clinical biomarker of inflammation because 301 
it is easily and reliably measured and it has been related to adiposity and cardiovascular 302 
risk factors in healthy children.(26) Moreover, CRP has been related to the prediction of 303 
coronary heart disease (27) and atherosclerosis in adults (28). However, based on our 304 
findings, it would be recommended to investigate other biomarkers related to traditional 305 
metabolic risk factors, in addition to CRP, to evaluate the inflammatory status.  306 
 307 
Cardiorespiratory fitness can be considered as a marker of cardiovascular health in 308 
children and adolescents (29) and has been related to an increased prevalence of CVD 309 
risk factors in adolescents and adults (30). A previous study with HELENA data 310 
showed that higher levels of cardiorespiratory fitness were positively associated with 311 
the ICHI in adolescents.(14) Our results show that the ICHI was associated with 312 
inflammation independently of cardiorespiratory fitness in girls.  313 
 314 
There were several limitations to our findings.  First, the cross-sectional nature of the 315 
study is a limitation. The inflammatory score is sample specific and each biomarker 316 
weighted equally for the prediction of cardio-metabolic risk. Blood samples only reflect 317 
inflammation at this specific time point. However, this study has many strengths 318 
including the use of an inflammatory score that sums up several inflammatory 319 
biomarkers, related to cardio-metabolic risk to assess an overall cardio metabolic status 320 
as well as the use of standardized and harmonized information from 9 European 321 
countries.  322 
 323 
In conclusion, results from the current study show that there is an association between 324 
the ideal cardiovascular health in adolescence and inflammatory status. Despite not 325 
being significant for CRP, results were strongly associated with a composite index of 326 
inflammation including CRP, WBC, C3, C4 and leptin, in both gender, and, in girls, 327 
independently of the cardiorespiratory. Since the most difficult ICHI criteria to achieve 328 
was ideal diet, we should concentrate efforts to improve consumption of those food 329 
items included in the index, especially emphasizing the reduction of salt intake. These 330 














cardiovascular risk. Longitudinal studies in adolescent populations measuring the 332 
association between inflammation and cardiovascular risk are needed to confirm these 333 
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SD: Standard deviation. PA: Physical activity. BMI: Body mass index. CRP: C-reactive protein. C: 597 
Complement factor. WBC: Whole blood cells count. ICHI: Ideal cardiovascular health index. 598 
Mean ± SD   Boys (n=251 ) Girls (n=292) p 
Age (years)  14.80±1.28 14.81±1.17 0.911 
Tanner I % (n) 0.8 (2) 0 (0) 0.126 
Tanner II % (n) 12.4 (31)  6.9 (20) 0.028 
Tanner III % (n) 17.6 (44) 24.5 (71) 0.054 
Tanner IV % (n) 46.0 (115)  45 (132) 0.887 
Tanner V % (n) 23.2 (58) 23.1 (67) 0.964 
Moderate-vigorous PA (min/day) 121.73±91.47 90.89±72.21 <0.001 
BMI (kg/m2) 21.04±3.96 21.14±3.38 0.763 
Systolic blood pressure (mm Hg) 120.10±14.04 112.85±11.19 <0.001 
Diastolic blood pressure (mm Hg) 64.02±8.61 65.04±8.72 0.174 
Glucose (mg/dL) 92.21±6.93 88.43±5.99 <0.001 
Total cholesterol (mg/dL)  152.60±26.06 167.67±27.49 <0.001 
Inflammatory score -0.02±3.23 0.14±3.06 0.517 
CRP (mg/L) 0.82±1.18 0.85±1.27 0.781 
C3 (g/L) 1.11±0.16 1.13±0.16 0.089 
C4 (g/L) 0.20±0.06 0.21±0.06 0.271 
Leptin (ng/mL) 9.17±14.93 29.1±25.06 <0.001 
WBC (10x3/ µL) 6.06±1.34 6.45±1.55 0.002 
Ideal health behaviours     
  Smoking % (n) 61.8 (155) 59.2 (173) 0.552 
  Body mass index % (n) 78.5 (197) 82.9 (242) 0.195 
  Physical activity % (n) 70.5 (177) 59.9 (175) 0.010 
  Diet % (n) 0 (0) 9 (3.1) - 
Ideal health factors     
  Total cholesterol % (n) 78.5 (197) 53.4 (156) <0.001 
  Blood pressure % (n) 88.8 (223) 90.1 (263) 0.643 
























95% CI: Confidence Interval. CRP: C-reactive protein. C: Complement factor. WBC: Whole blood cells count.  609 
*CRP and Leptin are log-transformed. 610 
Model 1: Adjusted by tanner and socioeconomic status (SES) 611 
Model 2: Adjusted by tanner, SES, and cardiorespiratory fitness. 612 
 Model 1  Model 2  











Beta 95% CI P Beta 95% CI P 
-0.794 -1.146, -0.442 <0.001 -0.597 -1.014, -0.181 0.005 
CRP* CRP* 
Beta 95% CI P Beta 95% CI P 
-0.040 -0.183, -0.096 0.540 0.029 -0.140, 0.199 0.732 
C3 C3 
Beta 95% CI P Beta 95% CI P 
-0.297 -0.047, -0.011  0.001 -0.017 -0.037, 0.003 0.110 
C4 C4 
Beta 95% CI P Beta 95% CI P 
-0.011 -0.018, -0.004 0.002 -0.012 -0.021, -0.004 0.004 
WBC WBC 
Beta 95% CI P Beta 95% CI P 
-0.077 -0.229, 0.074 0.315 -0.045 -0.226, 0.136 0.625 
Leptin* Leptin* 
Beta 95% CI P Beta 95% CI P 

























95% CI: Confidence Interval. CRP: C-reactive protein. C: Complement factor. WBC: Whole blood cells count.  624 
*CRP and Leptin are log-transformed. 625 
Model 1: Adjusted by tanner and socioeconomic status (SES) 626 
Model 2: Adjusted by tanner, SES, and cardiorespiratory fitness.627 
 Model 1  Model 2  











Beta 95% CI P Beta 95% CI P 
-0.646 -0.973, -0.319 <0.001 -0.52 -0.885, -0.155 0.005 
CRP* CRP* 
Beta 95% CI P Beta 95% CI P 
-0.102 -0.240, 0.035 0.145 -0.017 -0.180, 0.145 0.831 
C3 C3 
Beta 95% CI P Beta 95% CI P 
-0.036 -0.054, -0.019 <0.001 -0.034 -0.053, -0.015 0.001 
C4 C4 
Beta 95% CI P Beta 95% CI P 
-0.012 -0.019, -0.005 0.001 -0.008 -0.016, -0.0004 0.039 
WBC WBC 
Beta 95% CI P Beta 95% CI P 
-0.202 -0.366, -0.037 0.017 -0.157 -0.358, 0.043 0.123 
Leptin* Leptin* 
Beta 95% CI P Beta 95% CI P 














Table 4. Multilevel logistic regression. 628 
 629 
 Model 1 Model 2 
BOYS OR 95% CI p-value OR 95% CI p-value 
ICHI 0.693 0.544-0.883 0.003 0.735 0.533-1.014 0.061 
GIRLS  OR 95% CI p-value OR 95% CI p-value 
ICHI 0.677 0.539-0.850 <0.001 0.719 0.534-0.969 0.031 
 630 
OR: Odds ratio  631 
Model 1: Adjusted by tanner and socioeconomic status (SES) 632 
Model 2: Adjusted by tanner, SES, and cardiorespiratory fitness. 633 



















FIGURE LEGENDS 640 
 641 
Figure 1. Association between inflammatory score and Ideal Cardiovascular Health 642 
index. 643 
 644 






























Less than ideal cardiovascular health is associated with inflammation in adolescence 
C-reactive protein was not associated with cardiovascular health 
Diet is the component of the cardiovascular index most difficult to achieve 
Prevention should start early in life to avoid future cardiovascular diseases 
 
 
 
